832 reports of this reaction
2.3% of all INTERFERON BETA 1B reports
#10 most reported adverse reaction
INJECTION SITE REACTION is the #10 most commonly reported adverse reaction for INTERFERON BETA 1B, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 832 FDA adverse event reports linking INTERFERON BETA 1B to INJECTION SITE REACTION. This represents approximately 2.3% of all 36,175 adverse event reports for this drug.
Patients taking INTERFERON BETA 1B who experience injection site reaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INJECTION SITE REACTION is a less commonly reported adverse event for INTERFERON BETA 1B, but still significant enough to appear in the safety profile.
In addition to injection site reaction, the following adverse reactions have been reported for INTERFERON BETA 1B:
The following drugs have also been linked to injection site reaction in FDA adverse event reports:
INJECTION SITE REACTION has been reported as an adverse event in 832 FDA reports for INTERFERON BETA 1B. This does not prove causation, but indicates an association observed in post-market surveillance data.
INJECTION SITE REACTION accounts for approximately 2.3% of all adverse event reports for INTERFERON BETA 1B, making it a notable side effect.
If you experience injection site reaction while taking INTERFERON BETA 1B, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.